Drug details

Hyftor (sirolimus)

type of Immunosuppressive Agents, Topical

Hyftor (sirolimus topical gel) is an mTOR inhibitor immunosuppressant indicated for the treatment of facial angiofibroma associated with tuberous sclerosis in adults and pediatric patients 6 years of age and older.

This drug may have the following side effects:

• itching,
• dry skin,
• eye redness,
• acne,
• application site irritation,
• dermatitis,
• skin bleeding, and
• skin irritation.

The following drugs are related to Hyftor, either as a replacement or used together:

• Afinitor (everolimus tablets)
• Xcopri (cenobamate tablets)
• Dilantin (phenytoin)
• Dilantin 125 (phenytoin oral suspension)
• Zortress (everolimus)
• Keppra (levetiracetam)
• Keppra Injection (levetiracetam)
• Keppra XR (levetiracetam extended-release tablets)
• Vimpat (lacosamide tablet and injection)
• Phenytek Extended Release Capsule (phenytoin sodium)
• Topamax (topiramate)